Suppr超能文献

一氧化氮合酶阻断与血管紧张素转换酶阻断对清醒家兔肾功能的相互作用。

Interactions of blockade of nitric oxide synthase and angiotensin-converting enzyme on renal function in conscious rabbits.

作者信息

Evans R G, Rankin A J, Anderson W P

机构信息

Emily E. E. Stewart Renal Laboratory, Baker Medical Research Institute, Prahran, Victoria, Australia.

出版信息

J Cardiovasc Pharmacol. 1994 Oct;24(4):542-51. doi: 10.1097/00005344-199410000-00004.

Abstract

We tested the effects and interactions of blockade of nitric oxide (NO) synthase and angiotensin-converting enzyme (ACE) on renal function. Six rabbits were studied four times, each at 14-day intervals. The treatments were intravenous (i.v.) vehicle, NG-nitro-L-arginine (L-NNA) 5 mg/kg, captopril 500 micrograms plus 3.3 micrograms/kg/min, or L-NNA plus captopril. The studies were performed in random order. Arterial blood pressure (BP), heart rate (HR), and clearance of H2O, Na+, Li+, [3H]inulin [glomerular filtration rate (GRF)], and paraaminohippuric acid (PAH, renal plasma flow) were measured for the hour before treatment and for 3 h after treatment. Renal blood flow (RBF), renal vascular conductance, and GFR were reduced by 36 +/- 4, 41 +/- 4, and 17 +/- 5%, respectively, after L-NNA treatment. Although captopril did not affect these variables significantly when given alone, it completely abolished the effects of L-NNA. After L-NNA administration, sodium excretion decreased by 41 +/- 11%, chiefly attributable to reduced GFR, although increased reabsorption of sodium also contributed. The site of this increased reabsorption was probably the proximal nephron, since Li+ reabsorption (a marker of proximal tubular sodium reabsorption) tended to increase by 8.4 +/- 4.8%. Captopril had a natriuretic effect chiefly attributable to reduced sodium reabsorption in the proximal nephron. When these agents were coadministered, proximal tubular sodium reabsorption did not change significantly. Our data suggest the existence of a functional interaction between ACE and NO synthase in control of RBF and GFR.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们测试了一氧化氮(NO)合酶和血管紧张素转换酶(ACE)阻断对肾功能的影响及相互作用。对6只兔子进行了4次研究,每次间隔14天。治疗方法包括静脉注射(i.v.)溶媒、5mg/kg的NG-硝基-L-精氨酸(L-NNA)、500微克卡托普利加3.3微克/千克/分钟,或L-NNA加卡托普利。研究按随机顺序进行。在治疗前1小时和治疗后3小时测量动脉血压(BP)、心率(HR)以及水、钠、锂、[3H]菊粉清除率[肾小球滤过率(GRF)]和对氨基马尿酸(PAH,肾血浆流量)。L-NNA治疗后,肾血流量(RBF)、肾血管传导率和肾小球滤过率分别降低了36±4%、41±4%和17±5%。单独给予卡托普利时,虽然对这些变量无显著影响,但它完全消除了L-NNA的作用。给予L-NNA后,钠排泄减少了41±11%,主要归因于肾小球滤过率降低,尽管钠重吸收增加也有一定作用。这种重吸收增加的部位可能是近端肾单位,因为锂重吸收(近端肾小管钠重吸收的标志物)倾向于增加8.4±4.8%。卡托普利的利钠作用主要归因于近端肾单位钠重吸收减少。当这些药物联合使用时,近端肾小管钠重吸收无显著变化。我们的数据表明,在肾血流量和肾小球滤过率的控制中,ACE和NO合酶之间存在功能相互作用。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验